ArticleEJNMMI reports2026
Comparison of urinary bladder activity from [
Article in EJNMMI reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
aimPET/CT with radiolabelled PSMA-ligands has become the mainstay of diagnostic imaging for prostate cancer. The several available PSMA tracers differ modestly with respect to their avidity for lesions, but show distinct patterns of off-target uptake and routes of excretion. We sought to compare urinary bladder activity from [68Ga]Ga-PSMA-11 and [18F]PSMA-1007 with regard to their differing renal elimination, which can interfere in the detection of perivesical lesions. MATERIALS AND
methodsWe retrospectively compared urine activity in patients undergoing PET/CT after injection of either [68Ga]Ga-PSMA-11 patients in combination with hydration and diuresis (n = 132) or [18F]PSMA-1007 patients without hydration and diuresis (n = 100). Furthermore, we compared urinary bladder uptake from [18F]PSMA-1007 with lesional uptake in locally recurrent prostate cancer and locoregional lymph node metastasis, and performed an exploratory analysis of urine activity from [18F]PSMA-1007 relative to patient characteristics.
resultsUrine activity from [68Ga]Ga-PSMA-11 was normally distributed, being lowest in acquisitions 90 min p.i. with oral hydration and a single dose of furosemide injected 60 min after the tracer. In contrast, urine activity from [18F]PSMA-1007 followed an exponential distribution in the population, with approximately one quarter of cases exceeding an SUVmean threshold of 7. Urine activity of [18F]PSMA-1007 exceeded the uptake in prostate cancer lesions in more than 20% of patients.
conclusionsUrinary uptake from [18F]PSMA-1007 was in the range of that seen in [68Ga]Ga-PSMA-11 patients with hydration and diuretics. Some 25% of the [18F]PSMA-1007 cases showed problematic urinary uptake, which would potentially eclipse the uptake in prostate cancer lesions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.